Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Scilipoti

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate CancerPietro Scilipoti, Ola Bratt, Hans Garmo, et al.
Urolithiasis|June 13, 2026
Diagnostic performance of intraoperative urine dipstick testing during ureteroscopy: association with culture positivity and severe infectionCarlos González González, Pietro Scilipoti, Federico Zorzi, et al.
European Urology Focus|March 26, 2026
Minimally Invasive Surgical Therapies in Patients with Catheter-Dependent Urinary Retention: A Collaborative Mini-reviewPietro Scilipoti, Marie Chicaud, Mikael Abi Abdallah, et al.
European Urology|June 19, 2026
The Shifting Geography of Innovation in EndourologyPietro Scilipoti, Frederic Panthier, Davide Perri, et al.
BJU International|July 8, 2026
Prostate morcellation devices: a systematic review and meta-analysis of clinical outcomes and efficiencyStessy Kutchukian, Pietro Scilipoti, Mikael Abi Abdallah, et al.
European Urology|January 1, 2026
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC TrialsPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Clinical Genitourinary Cancer|March 3, 2026
Efficacy and Safety of Intravesical Gemcitabine and Docetaxel Combination Therapy in Patients With Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisPiotr Domański, Karolina Hanusz, Łukasz Zapała, et al.
BJU International|March 22, 2025
Acute kidney disease after radical cystectomy for bladder cancer: a new onco-nephrological viewFrancesco Trevisani, Matteo Floris, Mattia Longoni, et al.
European Urology Focus|June 13, 2026
Paclitaxel Drug-coated Balloon (Optilume) for Ureteral Stricture Management: Technical Description and Initial Clinical ExperienceFederico Zorzi, Pietro Scilipoti, Ahmed Alanazi, et al.
Theranostics|March 17, 2025
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysisGaia Ninatti, Pietro Scilipoti, Cristiano Pini, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate CancerPietro Scilipoti, Ola Bratt, Hans Garmo, et al.
Urolithiasis|June 13, 2026
Diagnostic performance of intraoperative urine dipstick testing during ureteroscopy: association with culture positivity and severe infectionCarlos González González, Pietro Scilipoti, Federico Zorzi, et al.
European Urology Focus|March 26, 2026
Minimally Invasive Surgical Therapies in Patients with Catheter-Dependent Urinary Retention: A Collaborative Mini-reviewPietro Scilipoti, Marie Chicaud, Mikael Abi Abdallah, et al.
European Urology|June 19, 2026
The Shifting Geography of Innovation in EndourologyPietro Scilipoti, Frederic Panthier, Davide Perri, et al.
BJU International|July 8, 2026
Prostate morcellation devices: a systematic review and meta-analysis of clinical outcomes and efficiencyStessy Kutchukian, Pietro Scilipoti, Mikael Abi Abdallah, et al.
European Urology|January 1, 2026
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC TrialsPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Clinical Genitourinary Cancer|March 3, 2026
Efficacy and Safety of Intravesical Gemcitabine and Docetaxel Combination Therapy in Patients With Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisPiotr Domański, Karolina Hanusz, Łukasz Zapała, et al.
BJU International|March 22, 2025
Acute kidney disease after radical cystectomy for bladder cancer: a new onco-nephrological viewFrancesco Trevisani, Matteo Floris, Mattia Longoni, et al.
European Urology Focus|June 13, 2026
Paclitaxel Drug-coated Balloon (Optilume) for Ureteral Stricture Management: Technical Description and Initial Clinical ExperienceFederico Zorzi, Pietro Scilipoti, Ahmed Alanazi, et al.
Theranostics|March 17, 2025
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysisGaia Ninatti, Pietro Scilipoti, Cristiano Pini, et al.
Pageof 10